News

March 25, 2019March 25, 2019

Trial Begins Testing Blood-derived GRF6019 Therapy for Severe Alzheimer’s Disease

News

The first patient has been dosed in Alkahest‘s Phase 2 clinical trial testing its investigational therapy, GRF6019, in individuals with severe Alzheimer’s disease. The study (NCT03765762) was designed to assess ... Read more

March 22, 2019March 22, 2019

Biogen and Eisai Halt Phase 3 Trials Testing Aducanumab for Early Alzheimer’s

News

Two Phase 3 clinical trials testing the investigational therapy aducanumab in patients with early Alzheimer’s disease have been discontinued. Biogen and Eisai came to this decision after an analysis ... Read more

March 20, 2019March 20, 2019

Combination of 2 Dietary Compounds May Have Benefits for Alzheimer’s Patients, Mouse Study Suggests

News

Combining two dietary compounds found in green tea and carrots reversed cognitive deficits, lowered the accumulation of toxic amyloid beta, and reduced brain inflammation and oxidative damage in a ... Read more

March 18, 2019March 18, 2019

Dosing Starts in Phase 2 trial of Bryostatin-1 for Alzheimer’s

News

Neurotrope Bioscience announced that dosing of patients has started in its Phase 2 clinical trial to further evaluate Bryostatin-1, the company’s investigational candidate for the treatment of moderate to ... Read more

March 15, 2019March 15, 2019

Brains of People with Sleep Apnea Show Increased Tau Protein Aggregates

News

People with sleep apnea show increased accumulation of tau protein aggregates — a hallmark of Alzheimer’s disease — in brain regions linked to memory and spatial navigation, a study ... Read more

March 13, 2019March 13, 2019

Alzheimer’s Association and Women’s Alzheimer’s Movement Launch Campaign to Highlight Disease’s Impact on Women

News

Because a disproportionate number of Alzheimer’s disease patients and caregivers are women, the Alzheimer’s Association and The Women’s Alzheimer’s Movement (WAM) are leading a global movement to do something ... Read more

March 11, 2019March 11, 2019

Manipulating Brain Cells called Astrocytes May Ease Alzheimer’s Symptoms, Study Finds

News

Manipulating astrocytes — a type of cell in the brain — to deliver a protein that favors the survival of neurons can rescue cognitive function, including memory, in a ... Read more

March 8, 2019March 8, 2019

Hip Fracture in Older People Without Dementia May Be Sign of Undiagnosed Alzheimer’s

News

Abnormal levels of amyloid-beta and tau protein — two hallmarks of Alzheimer’s disease — were detected in the cerebrospinal fluid of older individuals without dementia who were hospitalized for ... Read more

March 6, 2019March 6, 2019

Alzheimer’s Disease Duration and Outcome Vary According to Ethnoracial Groups, Study Finds

News

Hispanic-American patients with Alzheimer’s disease tend to live significantly longer after disease onset and with milder cognitive decline than African-Americans and non-Hispanic whites, a study reports. The study, “Ethnoracial ... Read more

March 4, 2019March 4, 2019

Extract from Native California Plant Shows Neuroprotective Ability Against Alzheimer’s, Study Reports

News

Sterubin, an active chemical compound extracted from a native California plant, was found to hold neuroprotective and anti-inflammatory potential for Alzheimer’s disease, a study shows. The study, “Old age-associated ... Read more

Pin It on Pinterest